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he Board of Optometry is a consumer protection
agency within the Department of Consumer Affairs
(DCA). Established in Business and Professions Code
section 3000 et seq., the Board is charged with protecting
consumers from unsatisfactory eye care provided by incom-
petent, unlicensed, or unethical practitioners; enforcing the
provisions of the Optometry Practice Act; and educating lic-
ensees and the public on vision care issues. The Board's regu-
lations are codified in Division 15, Title 16 of the California
Code of Regulations (CCR).
The Board consists of nine members-six practicing
optometrists and three public members. The Governor ap-
points all the optometrist members and one public member;
the Assembly Speaker appoints
one public member; and the Sen- In September 2000, Gover
ate Rules Committee appoints bill that once again expani
one public member. The Board optometrists and the un
maintains eight standing com- supervise.
mittees to assist it in the perfor-
mance of its duties: Executive,
Enforcement, Licensing and Examination, Continuing Edu-
cation, Credentials, Legislation, Regulation, and Public Re-
lations. The Executive Officer and a permanent full-time staff
of six support the Board from its office in Sacramento.
The Board's duties include licensing individual optom-
etrists and branch offices, and registering optometric corpo-
rations; establishing educational and examination require-
ments for optometrists and additional certification require-
ments for those optometrists who use and prescribe thera-
peutic pharmaceutical agents; accrediting optometric educa-
tional institutions; administering licensing examinations; and
promulgating regulations related to the practice of optometry
in California. Assisted by DCA's Division of Investigation
and the Office of the Attorney General, the Board also inves-
tigates allegations of incompetent, unprofessional, and un-
lawful conduct by licensees, and takes disciplinary action,
including license revocation, when warranted.
The Board's operations are funded entirely through li-
censing fees. The fee for license renewal is $300, due on a
biennial basis. By statute, $16 of each renewal is paid to the
University of California for the advancement of optometric
research and the maintenance and support of the optometry
department.
The Board generally holds four regularly scheduled meet-
ings each year, typically in February, May, August, and No-
vember. The meeting locations rotate among Sacramento, Los
Angeles/Orange County, San Francisco, and San Diego. How-
ever, because of difficulties gathering a quorum, the Board
Toll-Free Information Number:
last met to conduct business in December 2000. By statute, a
quorum of six members must appear at a Board meeting in
order to conduct business. One optometrist member's grace
year expired on June 1,2000; on June 1,2001, the grace years
of two other optometrist members expire, leaving only the
minimum number of members required to constitute a quo-
rum. All three vacancies must be filled by Governor Davis.
MAJOR PROJECTS
Optometrists' Scope of Practice Expanded Again
In September 2000, Governor Davis signed SB 929
(Polanco) (Chapter 676, Statutes of 2000), a bill that once




Davis signed SB 929, a for optometrists and the unlicensed
he scope of practice for assistants they supervise.
ensed assistants they t The first major scope of prac-
tice expansion for California op-
tometrists occurred in early 1996
with then-Governor Wilson's ap-
proval of SB 668 (Polanco) (Chapter 13, Statutes of 1996),
an urgency bill sponsored by the California Optometric As-
sociation (COA). Prior to the passage of SB 668, the practice
of optometry included only measurement and correction of
vision defects; "diagnosis" of conditions of the eye was pro-
hibited, as was the prescription of drugs. Optometrists could
use certain kinds of topical drugs solely for the purpose of
eye examinations, but no other drugs could be dispensed or
prescribed. SB 668 required the Board of Optometry to cre-
ate a new program to "certify" optometrists who meet certain
qualifications and -as to those optometrists only-amended
Business and Professions Code section 3041 to expand the
scope of practice to include diagnosis and treatment of a lim-
ited number of specified conditions of the eye. Such treat-
ment may include the use and prescription of a limited num-
ber of specified therapeutic pharmaceutical agents (TPA).
To qualify for TPA certification, most optometrists must:
(1) complete an 80-hour didactic course provided by an ac-
credited California school of optometry or by a recognized resi-
dency review committee in ophthalmology in California, and
pass an examination administered upon completion of the
course; (2) complete a structured 65-hour preceptorship dur-
ing no less than a two-month period in either an
ophthalmologist's office or an optometric clinic; (3) complete
a minimum of 20 hours of self-directed education; and (4) pass
the National Board of Examiners in Optometry's (NBEO)
"Treatment and Management of Ocular Disease" examination
or an equivalent exam approved by the Board of Optometry.
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SB 668 also created a six-member TPA Advisory Com-
mittee within the Board of Optometry, consisting of three
optometrists appointed by the Board and three ophthalmolo-
gists appointed by the Medical Board of California. The TPA
Advisory Committee was charged with recommending pro-
tocols that the Board of Optometry could use in its
decisionmaking process, including protocols relating to pe-
ripheral infectious corneal ulcers and for deciding issues re-
lating to the equivalency of education and training of optom-
etrists licensed outside California.
The 1996 passage of SB 668 was a long time in coming;
the bill was preceded by AB 3242 (Isenberg) in 1992 [12:4
CRLR 114; 12:2&3 CRLR 1331,AB 2020 (Isenberg) in 1993-
94 [14:4 CRLR 89; 14:2&3 CRLR 94], and SB 510 (Maddy)
in 1995 [15:4 CRLR 112], none of which were successful in
overcoming the opposition of organized medicine. By 1996,
however, at least 45 other states permitted optometrists to di-
agnose and treat a limited category of eye diseases, and the
bill's proponents argued that expanding the practice of optom-
etrists would increase patient access to primary eye care at lower
cost. Regardless of its merits, SB 668 did not enjoy much pub-
lic scrutiny or debate. As it moved through many legislative
committees during 1995, SB 668 pertained only to clarifica-
tion of the duties of ancillary personnel who work in optom-
etrists' offices. [15:4 CRLR 112] However, that language was
gutted in a conference committee on January 31, 1996, and the
conference committee report was passed by the legislature and
signed by the Governor only three weeks later without the ben-
efit of any legislative policy committee hearing. The legisla-
ture included intent language in the
bill prohibiting further expansion SB 929-also sponsored
of the scope of practice of optom- extensive private negoti
etry until January 1, 2000. California Academy
As 2000 approached, the op-
tometry profession fashioned the eventually took a neutral
next expansion of its scope of thegfac tatill t
practice, which took the form of program substantially, t
SB 929 (Polanco). SB 929-also
sponsored by COA-was the
product of extensive private negotiations between COA and
the California Academy of Ophthalmology, which eventu-
ally took a neutral position on the bill. Despite the fact that
the bill would change its regulatory program substantially,
the Board was excluded from the negotiations. The Califor-
nia Medical Association ultimately opposed the bill.
Effective January 1, 2001, SB 929 expands the practice
of optometry to include "the prevention and diagnosis of dis-
orders and dysfunctions of the visual system, and the treat-
ment and management of certain disorders and dysfunctions
of the visual system, as well as the provision of rehabilitative
optometric services...." The bill expands the list of services
that may be provided by TPA-certified optometrists to include
treatment of a specific list of additional conditions detailed
in Business and Professions Code section 3041(b). These
conditions include:
• infections of limited portions of the anterior segment
and adnexa, for patients other than those with AIDS;
• ocular allergies of the anterior segment and adnexa;
" ocular inflammation that is nonsurgical in cause, and
that results from specified causes;
• ocular pain associated with conditions that optometrists
may lawfully treat, other than pain related to a surgical pro-
cedure;
- primary open angle glaucoma, but only if the patient is
over the age of 18 and the optometrist has been specially cer-
tified by the Board. To become certified, an optometrist must
(1) successfully complete a didactic course of not less than
24 hours in the diagnosis, pharmacological, and other treat-
ment and management of glaucoma, which course must be
"developed by an accredited California school of optometry,"
(2) provide collaborative treatment with an ophthalmologist
of at least fifty glaucoma patients for a period of at least two
years, and (3) provide documentation of the qualifying col-
laborative treatment to the Board; and
* lacrimal irrigation and dilation (excluding probing of the
nasal lacrimal tract), but only if(l) the patient is over 12 years
of age, and (2) the optometrist is specially certified by the Board.
To be certified, the optometrist must complete ten of these pro-
cedures under the supervision of an ophthalmologist.
The bill also amends Business and Professions Code sec-
tion 3041(c) to expand the list of medications that TPA-certi-
fled optometrists may use to include topical steroids, topical
antiglaucoma agents (provided the optometrist is certified to
treat glaucoma), oral antihistamines (subject to specific re-
quirements governing mandatory
consultation with and referral of
COA-was the product of patients to an ophthalmologist),ins between COA and the
some prescription oral nonsteroi-Ophthalmology, which dal anti-inflammatory agents
0sition on the bill. Despite (subject to a mandatory referral
Bd hages eulatrory to an ophthalmologist if the con-
dition has not resolved within
three days), specified oral antibi-
otics, topical antiviral medication
and oral acyclovir for the treatment of specified diseases (sub-
ject to disease-specific requirements governing mandatory
consultation with and referral to an ophthalmologist), oral
analgesics that are not controlled substances, and codeine and
hydrocodone with compounds as listed in Health and Safety
Code section 11000 (limited to three days' use and referral to
an ophthalmologist if pain persists). Where the statute requires
an optometrist to consult with and/or refer patients to an oph-
thalmologist, it also requires the optometrist to maintain spe-
cific written records in the patient's file, and further autho-
rizes the ophthalmologist to have access to those records.
SB 929 also revises the Board's continuing education
(CE) requirements for optometrists who are TPA-certified.
Of the 50 hours of CE required every two years, 35 hours
must be completed as follows: twelve hours on glaucoma,
ten hours on ocular infections, five hours on inflammation
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and topical steroids, six hours on systemic medications; and
two hours on the use of pain medications.
SB 929 amends Business and Professions Code section
2544 to expand the scope of practice of assistants acting un-
der the direct supervision of an optometrist. Previously lim-
ited to fitting prescription lenses, optometric assistants-who
are unlicensed-may now additionally prepare patients for
examination; collect preliminary patient data, including tak-
ing a patient history; perform simple noninvasive testing of
visual acuity, pupils, and ocular motility; perform automated
visual field testing; perform ophthalmic photography and digi-
tal imaging; perform tonometry and lensometry; perform
nonsubjective auto refraction in connection with subjective
refraction procedures performed by an optometrist; adminis-
ter cycloplegics, mydriatics, and topical anesthetics that are
not controlled substances, for ophthalmic purposes; and per-
form pachymetry, keratometry, A scans, B scans, and
electrodiagnostic testing.
At one point, SB 929 would have created a
"Multidisciplinary Committee" within the Board of Optom-
etry. The Committee-consisting of three optometrists ap-
pointed by the Board of Optometry, three ophthalmologists
appointed by the Medical Board, and three pharmacists ap-
pointed by the Board of Pharmacy-would have been autho-
rized to add drugs and laboratory tests to those listed in sec-
tion 3041 for the purpose of treating diseases and conditions
authorized therein, and to add procedures to be performed by
medical and optometric assistants pursuant to section 2544.
Due to opposition by the California Medical Association, this
provision was stricken from the final version of the bill. The
bill also repeals Business and Professions Code section
3041.1, which previously mandated the creation of the Board's
TPA Advisory Committee (see above).
Finally, SB 929 expresses the intent of the legislature
that no legislation amending the scope of practice of optom-
etry shall be introduced prior to January 1,2008, and no such
legislation shall be passed prior to January 1, 2009.
Proponents of SB 929 emphasized that, even as expanded,
the scope of practice of California optometrists is still nar-
rower than in most other states, and insisted that optometrists
are fully trained to perform the newly added functions. Sup-
porters also argued that the bill will provide California con-
sumers with a greater array of treatment options and reduce
unnecessary referrals and duplicative office visits. Due to the
bill's complexity and its numerous requirements for referrals
and co-management of certain conditions by optometrists and
ophthalmologists, only time will tell whether patients and
public protection have been served by this bill.
SB 929 Rulemaking
Following the passage of SB 929 (Polanco) (see above),
Board President Gerald Easton appointed optometrist mem-
ber Steven Grant and public member Jane Vogel to a special
committee charged with making recommendations on whether
the Board should adopt regulations to implement any portion
of the bill. On November 7, 2000, the special committee met
and formulated the following recommendations:
(1) regarding the tasks that may be performed by unli-
censed optometric assistants, the Board should define by regu-
lation the phrase "prepare patients for examination" in Busi-
ness and Professions Code section 2544 to mean tasks not
requiring professional judgment or skills;
(2) the Board should amend section 1567, Title 16 of the
CCR, to define the term "consultation" to include (but not be
limited to) communication by telephone, writing, fax, email,
or other electronic means (except as provided in Business
and Professions Code section 3041 (c)(7)(C) regarding glau-
coma consultations);
(3) the Board should define in regulation the process for
certifying optometrists to perform lacrimal irrigation and di-
lation, as provided in Business and Professions Code section
3041(e)(6);
(4) the Board should adopt regulations implementing
Business and Professions Code section 3041(f)(1), to estab-
lish equivalency criteria for 24-hour glaucoma certification
courses developed by course providers other than "an accred-
ited California school of optometry";
(5) the Board should define in regulation the process for
certifying optometrists to treat primary open angle glaucoma,
as provided in Business and Professions Code section
3041(f)(3);
(6) the Board should adopt regulations governing the
process and required proof of completion to be provided by
an optometrist as evidence of collaboration with an ophthal-
mologist on fifty glaucoma patients, if the ophthalmologist
fails to provide documentation of the collaboration under
Business and Professions Code section 3041(f)(3); and
(7) the Board should amend section 1531, Title 16 of the
CCR, to require successful completion of Part III (patient care)
of the National Board of Examiners in Optometry's exami-
nation in lieu of the Board's clinical skills examination.
At its December 1, 2000 meeting, however, the Board re-
jected most of the special committee's recommendations. Spe-
cifically, the Board voted to take no regulatory action to imple-
ment Business and Professions Code sections 2544 (tasks of
unlicensed assistants) and 3041(f)(3) (proof of completion of
ophthalmologist collaboration on glaucoma patients if the oph-
thalmologist fails to provide documentation). Rather than adopt
regulations, the Board decided to create a form to implement
sections 3041 (e)(6) (process for certifying optometrists to per-
form lacrimal irrigation and dilation) and 3041(f)(3) (process
for certifying optometrists to treat primary open angle glau-
coma). The Board decided to further research the special
committee's proposals for rulemaking to define the term "con-
sultation" and specify equivalency criteria for the 24-hour
course required for glaucoma certification.
As to the licensing exam, optometrist member Steven
Grant repeated comments he had made at several prior meet-
ings that SB 929 has now expanded California optometrists'
scope of practice sufficiently to permit the Board to adminis-
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ter Part III of the NBEO exam in lieu of its own clinical skills
examination. By a vote of 5-2, the Board passed a motion
authorizing the creation of a committee to draft proposed lan-
guage and set for hearing a regulatory amendment requiring
applicants for licensure to pass Parts 1, 11, and III of the NBEO
examination instead of the Board-administered practical exam.
Board president Easton appointed optometrist members
Steven Grant and John Anthony to the committee (see below
for further details).
Examination Regulation on Hold
On December 29, 2000, the Board published notice of
its intent to amend section 1531, Title 16 of the CCR, to per-
mit the Board to use NBEO's Part III Patient Care test in
place of its own clinical skills examination (see above). Un-
der the Board's proposal, section 1531 would be amended to
provide that the Board's licensure examination requirement
consists of passage of Parts I (basic science), II (clinical sci-
ence), and III (patient care) of the NBEO's exam, plus pas-
sage of a "California laws and regulations" test developed by
the Board or its contractor.
After a hearing at a special meeting on February 15,2001,
the Board approved the amendments and forwarded the
rulemaking file to DCA. However, the Department-and spe-
cifically its Office of Examination Resources (OER)-ex-
pressed concern that the Board had not presented sufficient
evidence that Part III of the NBEO provides an effective means
of assessing the entry-level competence of prospective Cali-
fornia optometrists. DCA suggested that, at minimum, OER
and the Board compare OER's recently-completed occupational
analysis of the optometry profession in California (which was
completed by OER [17:1 CRLR 56] and submitted to the Board
in April 2001) with the contents of Part III of the national exam
to determine if there is a sufficient linkage between Part III
and the practice analysis for the examination to be legally de-
fensible in California. At this writing, OER plans to ask NBEO
to undertake a comparison of the California practice analysis
and Part III of its exam, and to ask the Board to undertake a
cross-validation study of its own, independent of NBEO. Upon
completion of both studies, DCA will consider the Board's pro-
posed regulatory change to section 1531.
Update on Other Board Rulemaking Proceedings
The following is an update on Board rulemaking pro-
ceedings described in more detail in Volume 17, No. 1 (Win-
ter 2000) of the California Regulatory Law Reporter:
* CE via the Internet. At this writing, the Board has
indefinitely postponed action on regulatory amendments to
section 1536, Title 16 of the CCR, which would have revised
the Board's continuing education (CE) requirements and per-
mitted optometrists to fulfill part of their CE requirement via
approved courses offered over the Internet. This proposal has
proven somewhat controversial: It was the subject of an Au-
gust 1998 public hearing, continued discussion at the Board's
November 1998, March 1999, and May 1999 meetings, and
a survey of other state optometry boards and DCA occupa-
tional licensing boards undertaken by Board staff. [17:1 CRLR
55; 16:2 CRLR 46-47; 16:1 CRLR 67-68]
* Disciplinary Guidelines. On February 18, 2000, the
Board published notice of its intent to amend section 1575,
Title 16 of the CCR. The amendment requires the Board, in
reaching a decision in a disciplinary matter, to consider the
most recent version of its disciplinary guidelines, last modi-
fied in May 1999. The prior language of section 1575 re-
quired the Board to use the 1996 version of its "Disciplinary
Guidelines and Model Disciplinary Orders." [17:1 CRLR 55]
Following a public hearing at its April 7, 2000 meeting, the
Board adopted the proposed change. The Office of Adminis-
trative Law (OAL) approved the change on April 25, 2001.
* Appeal of Exam Results. Also on February 18, 2000,
the Board published notice of its intent to repeal section
1533. 1,Title 16 of the CCR, which permitted candidates who
failed the Board's licensing exam to appeal their scores. [17:1
CRLR 55] Following a public hearing at its April 7, 2000
meeting, the Board adopted the proposed change. On April
25, 2001, OAL approved the repeal of section 1533.1.
* Inspection of FailedExam.Also on February 18, 2000,
the Board published notice of its intent to repeal section 1533,
Title 16 of the CCR, which previously permitted licensure
candidates who had failed the Board's exam to inspect their
examination papers in order to review the questions they
missed, upon written request. [17:1 CRLR 55] After a public
hearing on April 7. 2000, the Board unanimously approved
the change. Thereafter, DCA Director Kathleen Hamilton
expressed concerns about the Board's proposal. At its Febru-
ary 15, 2001 meeting, the Board reconsidered and decided
instead to modify the language of section 1533. As modified,
the provision would permit an examinee who has failed any
section of the Board's exam to request that his/her examina-
tion papers be rescored by the Board. Such a request must be
made in writing within 75 days after the date the examination
results are mailed. At this writing, OAL is reviewing the
rulemaking file on this proposed regulatory change.
* Repeal of Diagnostic Drug Formulary. Also on Feb-
ruary 18, 2000, the Board published notice of its intent to
repeal section 1560, Title 16 of the CCR. Section 1560 set
forth the kinds of topical pharmaceutical agents that optom-
etrists may use and the concentrations in which they may be
used. According to the Board, regulatory section 1560 has
been superseded by Business and Professions Code section
3041(a)(5), added by SB 929 (Polanco) (see 2000 LEGIS-
LATION). That section now provides that optometrists may
use topical pharmaceutical agents "includ[ing] mydriatics,
cycloplegics, anesthetics, and agents for the reversal of my-
driasis." [17:1 CRLR 55] OAL approved the Board's repeal
of section 1560 on April 6, 2001.
Board to Form Consumer Advisory Committee
After discussing the matter at its April and July 2000
meetings, the Board voted to appoint a Consumer Advisory
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Committee at its December 2000 meeting. According to Ex-
ecutive Officer Karen Ollinger, the next step will be to sub-
mit a budget change proposal to DCA in order to arrange for
payment of the costs associated with such a committee. Pub-
lic member Sunil Aghi, who made the original motion to cre-
ate the committee, reported that he had been in contact with
DCA officials and that they were supportive of the idea and
willing to help the Board request the necessary funding.
2000 LEGISLATION
SB 929 (Polanco), as amended August 24, 2000, expands
the definition of optometry and the scope of practice of optom-
etrists; enlarges in detailed fashion the types of conditions a
TPA-certified optometrist may treat (to include primary open
angle glaucoma) and under what conditions; expands the list
of TPAs that certified optometrists may dispense and prescribe
under specified circumstances; requires optometrists to con-
sult with and/or refer patients to ophthalmologists in certain
circumstances, and requires optometrists to adhere to detailed
recordkeeping requirements in those circumstances; expands
the list of tasks that unlicensed optometric assistants may per-
form under the direct responsibility and supervision of an op-
tometrist; abolishes the Board's previously-existing TPA Ad-
visory Committee; and expresses the legislature's intent that
the scope of practice of optometrists remain unchanged until
2009 (see MAJOR PROJECTS for detailed background infor-
mation). SB 929 was signed by Governor Davis on September
24, 2000 (Chapter 676, Statutes of 2000).
SB 1889 (Figueroa), as amended August 23, 2000, clari-
fies Business and Professions Code section 27, which currently
requires the Board and other DCA agencies to post certain in-
formation on the Internet regarding their licensees. SB 1889
requires the Board to allow its licensees who use their home
address as their official "address of record" to provide a post
office box or other alternate address which will be posted on
the Internet. The bill also specifies that it does not preclude an
agency from also requiring a licensee who has provided an
alternative mailing address as his/her address of record to also
provide a physical business address or residence address only
for the entity's internal administrative use and not for disclo-
sure as the licensee's address of record or disclosure on the
Internet. This bill was signed by the Governor on September
29, 2000 (Chapter 927, Statutes of 2000).
AB 368 (Kuehl), as last amended August 7, 2000, would
have required health plans that provide prosthetic or visual
aids, health insurers, and Medi-Cal to provide coverage for
prosthetic or visual aids for individuals with "low vision."
[17:1 CRLR 56] The bill died in the Senate Appropriations
Committee.
2001 LEGISLATION
AB 269 (Correa), as amended April 5, 2001, would
create the Division of Enforcement Oversight within DCA.
Under the direction of the DCA Director, the Division
would monitor and evaluate the consumer complaint and
discipline system of each DCA board (including the Board
of Optometry). Further, the bill would require the execu-
tive officer of each DCA board to be appointed by a three-
member panel comprised of a representative of the board,
the DCA Director, and the Governor's appointments sec-
retary. [A. B&P]
AB 1095 (Wright), as amended April 30, 2001, would
require every child, within 90 days of entrance into the first
grade of a public or private school, to undergo a comprehen-
sive eye examination by an optometrist or ophthalmologist
that includes testing of vision skills that may impact a child's
ability to read. [A. Ed]
SB 606 (Vasconcellos), as amended April 17, 2001,
would require periodic screening of the tracking and fixa-
tion (the ability of the eyes to track movement), focusing
(how quickly the eyes can focus on an object), and
eye-teaming (how well the eyes work together) of the eyes
of schoolchildren; currently, the eye exams required of
schoolchildren test only visual acuity and color vision. If
the screening reveals any abnormalities suggesting a
vision-related problem that may affect a child's ability to
learn, the individual administering the test would be required
to provide the child's parent or guardian with a written state-
ment that it may be advisable for the child to see a physi-
cian or optometrist. [S. Ed]
AB 919 (Romero), as introduced on February 23, 2001,
and SB 1208 (Romero), as introduced March 19, 2001, are
identical bills. With certain exceptions, existing law estab-
lishes eight hours as one day's work and a 40-hour work-
week, and requires payment of prescribed overtime compen-
sation for additional hours worked. The Industrial Welfare
Commission (IWC) is permitted to establish exemptions from
the overtime requirements for executive, administrative, and
professional employees meeting certain criteria, one of which
is that the employee must earn a monthly salary equivalent to
no less than double the state minimum wage for full-time
employment. These bills would allow the IWC to exempt a
licensed physician, podiatrist, optometrist, or dentist earning
less than two times the minimum wage from the overtime
requirements, provided that he/she is employed to perform
duties for which licensure is required. [AB 919-A. Floor;
SB 1208-S. Appr]
LITIGATION
After six years of litigation, several major contact lens
manufacturers and the American Optometric Association
(AOA) recently settled a federal antitrust class action in which
the Attorneys General of 32 states-including California-
accused the defendants of conspiring to ensure that dispos-
able contact lenses are sold only through optometrists and
other eye care professionals who often mark up prices con-
siderably, and not through lower-priced pharmacies, Internet
businesses, and other outlets permitted to sell contact lenses.
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The case was originally filed by the Florida Attorney
General in 1994. [15:4 CRLR 113-14] Thirty-one other states
eventually joined the suit, In Re Disposable Contact Lens
Antitrust Litigation, No. MDL 1030 (M.D. Fla.), against
Bausch & Lomb, Ciba Vision, Vistakon (a subsidiary of
Johnson & Johnson), AOA, and several individual optom-
etrists. The states claim that the conspiracy began when dis-
posable contact lenses were first introduced in 1987. Accord-
ing to the National Association of Attorneys General, defen-
dants allegedly made a concerted effort to prevent lenses from
being sold by anyone other than a licensed eye care profes-
sional who was selling to his/her patient. Additionally, the
states charged that AOA and individual optometrists shared
ideas on how to keep patients from obtaining their contact
lens prescriptions, in order to prevent them from purchasing
lenses elsewhere. The New York Attorney General's Office,
one of the lead prosecutors of the action, asserted that 25
million Americans who wear soft contact lenses may have
been overcharged by as much as $600 million from January
1, 1988 to the present.
Ciba Vision settled the charges against it in 1997, agree-
ing to pay an estimated $30 million in rebates to consumers
who had purchased its products during the time period in
question plus $5 million in attorneys' fees and fines. In Feb-
ruary 2001, Bausch & Lomb settled just before trial, and
agreed to pay a total of $17.5 mil-
lion to end the lawsuit. Vistakon
and AOA refused to settle until The litigation is expe
several weeks after trial started on potentially Congress to
March 19, 2001. Vistakon will pay opetrits n pta
$30 million in rebates and $25 lens prescriptions to patie
million in attorneys' fees and
costs; AOA agreed to settle for
$750,000. All four defendants admitted no wrongdoing.
The litigation is expected to prompt states and poten-
tially Congress to enact legislation requiring optometrists and
ophthalmologists to release contact lens prescriptions to pa-
tients so they can choose where to purchase replacement
lenses. At the federal level, the Federal Trade Commission's
ophthalmic practice rules require the release of eyeglasses
prescriptions to patients but are silent as to contact lens pre-
scriptions. Although 26 states require the release of contact
lens prescriptions, neither the California Board nor the Cali-
fornia legislature has addressed the issue at this writing.
RECENT MEETINGS
At the Board's November 15, 1999 meeting, Board pub-
lic member Sunil Aghi addressed his colleagues during the
public comment session. Aghi expressed his desire for a pri-
vate meeting with the Attorney General's Office to discuss
what he perceived to be misconduct by the Board's Execu-
tive Officer, Karen Ollinger, for allegedly giving Board mem-
bers misinformation about the Board's budget status during
prior closed-session meetings to discuss enforcement-related
litigation the Board had previously approved and then aban-
doned. According to Aghi, he had repeatedly requested an
opportunity to discuss his concerns during a closed session,
but his requests were ignored or denied by optometrist Board
members. Aghi's comments were interrupted by Deputy At-
torney General Kent Harris, who warned Aghi about the dan-
gers of speaking about closed-session matters publicly. Pub-
lic member Jane Vogel inquired as to when would be an
appropriate time to hold a closed meeting to discuss the is-
sues that Aghi had introduced. The Board passed a motion
to hold a special board meeting with the Attorney General's
Office as soon as possible. The special closed session meet-
ing was scheduled for January 9, 2000, but was delayed sev-
eral times for various reasons before it actually took place
in the fall of 2000. Unfortunately, the 1999 incident por-
tended a growing rift between the Board's public members
and its optometrists members-a rift that has subsequently
paralyzed the Board.
Also in November 1999, the Board decided to drop the
idea of potentially seeking legislation to eliminate the licen-
sure category of several hundred licensees who hold valid
California optometrist licenses but have never been certified
to use diagnostic pharmaceutical agents (DPA), as authorized
in 1978 legislation. DPA certification is optional, and is not
currently required to maintain licensure as an optometrist.
However, with the passage of 1996 legislation authorizing
optometrists to pursue TPA certi-
fication to treat a limited number
Ito pro statresuand of eye conditions, the Board had
act legislation requiring previously expressed the opinion
logists to release contact that DPA certification should be
sothey can choose where a minimum requirement for op-
ses. tometric practice in California.
[17:1 CRLR 56; 16:2 CRLR 47-
48] After surveying its non-DPA licensees and considering
the responses, the Board decided to take no action at this time
to eliminate the non-DPA category of licensure.
Also in November 1999, the Board elected Gerald Easton,
OD, as president; Sheilah Titus, OD, as vice-president; and
public member Jane Vogel as secretary.
At the Board's July 29, 2000 meeting, Executive Officer
Karen Ollinger made a presentation regarding the Executive
Officer Exempt Level Review. In December 1999, the De-
partment of Personnel Administration (DPA) requested that
DCA conduct a comprehensive review of all California ad-
ministrative boards and provide an analysis of the appropri-
ate executive officer (EO) exempt level for each. Among other
things, the exempt level is used to determine the salary of the
EO. The last such review had been conducted in 1985. Based
on the results of this survey and analysis, DCA recommended
an EO exempt level adjustment from the current P2 (smallest
boards) to the proposed level 0 (small boards) for the Board
of Optometry. The Board approved DCA's recommendation.
Also at the July 29, 2000 meeting, the Committee on
Public Relations announced that a new issue of the Board's
newsletter had been completed and would be printed as well
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as posted on the Board's Web site. However, at this writing,
the most recent newsletter available on the Board's Web site
dates back to 1997. According to EO Ollinger, DCA must
first approve all Web site postings; apparently the new news-
letter was misplaced for some time in DCA bureaucracy, but
is now back on track and should be electronically posted in
the near future.
At its December 2000 meeting, the Board unanimously
reelected Gerald Easton, OD, as Board president and Sheilah
Titus, OD, as vice president. Steven Grant, OD, was selected
Board secretary.
Due to its failure to muster a quorum, the Board can-
celled its scheduled March 16-17,2001 meeting in Oakland.
FUTURE MEETINGS
2001: June 8-9 in Orange County; September 7-8 in
Sacramento; November 30-December 1 in San Diego.
2002: No meetings have been scheduled at this writing.
Board of Pharmacy
Executive Officer: Patricia Harris + (916) 445-5014 * Internet:www.pharmacy.ca.gov
ursuant to Business and Professions Code section 4000
et seq., the Board of Pharmacy grants licenses and per-
mits to pharmacists, pharmacy interns, pharmacy tech-
nicians, pharmacies, pharmacy corporations, nonresident
pharmacies, wholesale drug facilities, veterinary food-ani-
mal drug retailers, out-of-state distributors, clinics, and hy-
podermic needle and syringe distributors. It regulates all sales
of dangerous drugs, controlled substances, and poisons. The
Board is authorized to adopt regulations, which are codified
in Division 17, Title 16 of the California Code of Regula-
tions (CCR).
To enforce the Pharmacy Law and its regulations, the
Board employs full-time inspectors who investigate complaints
received by the Board. Investigations may be conducted openly
or covertly as the situation demands. The Board conducts fact-
finding and disciplinary hearings, and is authorized by law to
suspend or revoke licenses or permits for a variety of reasons,
including professional misconduct and any misconduct sub-
stantially related to the practice of pharmacy.
The Board of Pharmacy is a consumer protection agency
located within the Department of Consumer Affairs (DCA).
The Board consists of eleven members, four of whom are
public members. The Governor appoints two public mem-
bers and the Senate Committee on Rules and the Speaker of
the Assembly each appoint one. The remaining members are
pharmacists appointed by the Governor, five of whom must
be active practitioners. All Board members are appointed for
four-year terms.
In March 2000, Governor Davis appointed Donald W.
Gubbins, Jr., Pharm.D., to the Board. Dr. Gubbins is Regional
Pharmacy Development Manager for RiteAid Corporation.
In June 2000, the Senate Rules Committee named Will-
iam Powers as a public member of the Board. Powers is leg-
islative director of the Congress of California Seniors and is
also Coordinator of the Capital City Task Force for the Ameri-
can Association of Retired Persons (AARP).
MAJOR PROJECTS VV
State Auditor Critical of Board's
Enforcement System
In April 2001, the Bureau of State Audits (BSA) released
a report entitled Investigations of Improper Activities by State
Employees: July 2000 Through January 2001. In a chapter
entitled Board of Pharmacy: Gross Inefficiency in Process-
ing Consumer Complaints and Failure to Record and Pay
Overtime, BSA noted that it received an allegation that the
Board had a backlog of consumer complaints and was not
doing its job to investigate incoming complaints. BSA inves-
tigated and substantiated the allegation. Specifically, BSA
found that the Board's established timeframes to resolve com-
plaints-up to 290 days for complex complaints and 140 days
for all others-are excessive when compared to the
timeframes mandated by law or regulation for other consumer
protection agencies.
Second, BSA found that the Board fails to meet its own
excessive timeframes. Between January 1, 1994 and March
6, 2000, it took the Board an average of 441 days to close
5,265 complaints. Of those complaints, the Board resolved
only 35% of its high-risk complaints within 290 days and
only 20% of its less complex cases within its 140-day goal.
As of March 6,2000, the Board had not resolved 770 of 1,552
open complaints within its maximum 290-day goal. Although
the Board's goal is to complete the investigation phase of its
enforcement process within five months, BSA found that
Board staff takes on average nine months to complete inves-
tigations after the complaint is assigned to an inspector.
Third, BSA examined the Board's system for prioritiz-
ing complaints. Based on the subject matter of complaints,
the Board categorizes its high-risk complaints as Priority 1
(urgent-immediate), Priority 2 (rapid), Priority 3 (active in-
vestigation), or Priority 4 (standard, consistent turnaround).
BSA found that this system "does not ensure that complaints
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